entertainment -WSS

entertainment

author：knowledge 2025-09-29 22:52:35 - browse：9

Drugmakers already bet big on mRNA for cancer. Now President Biden is going in, too? Anna Moneymaker/Getty Images

WASHINGTON — President Biden’s fledgling health agency, designed to accelerate under-funded research, just set its sights on one of the hottest areas of medicine — and one where the drug industry has a multibillion-dollar head start.

The White House announced Wednesday that the Advanced Research Projects Agency for Health would bankroll a $24 million project by Emory University to build messenger RNA platforms to target “cancer and other diseases,” investing in the technology behind the U.S.’s most commonly used vaccines for Covid-19.

The administration touted the news of CUREIT as the latest in Biden’s longtime mission to rein in cancer deaths, the Cancer Moonshot. But by using mRNA to treat cancer, ARPA-H is wading into a field that has advanced in fits and starts — and whose industry leaders have already spent multiples of the program’s entire budget into their own research. Moderna and BioNTech, massively profitable companies that have sold more than $80 billion worth of Covid-19 vaccines combined, have singled out oncology as the next big application for mRNA and invested accordingly.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Marvel Studios reveals new trailer for 'The Marvels': Watch here

leisure time

WSS

As Taiwan prepares for anti

Court strikes down limits on filming of police in Arizona

ASCO: Palliative care found as helpful given virtually as in person

Court strikes down limits on filming of police in Arizona

CDC backtracks, saying fully vaccinated people can go maskless indoors

Providers still hesitate to prescribe buprenorphine, study finds

knowledge

entertainment

focus

Hollywood unions extend contract negotiations for actors

Shifting the focus from loneliness to social health

In Memoriam: Notable people who died in 2023

FDA official pushes for dedicated emerging pathogens team

BioMarin wins approval for gene therapy to treat hemophilia A

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Hollywood unions extend contract negotiations for actors

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Continuity nursing helped my family in our darkest PICU moments

Woman returns to dialysis after doctors remove transplanted pig kidney

focus

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Cord blood banking comes at a high cost to babies

See how much Covid

Shifting the focus from loneliness to social health

Shifting the focus from loneliness to social health

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

focus

leisure time

Wikipedia

hotspot